Kristen Kluska

Mar 09, 2026

Kristen Kluska rated RNAC as Overweight on Mar 09, 2026, setting a price target of 16. Shares have remained stable near 9.02, leaving the 16 target still in play.

Feb 17, 2026

IRON received a Overweight rating from Kristen Kluska on Feb 17, 2026, aiming for 153. Price action was muted, as shares hovered around 64.23 despite the bullish outlook.

Jan 15, 2026

On Jan 15, 2026, Kristen Kluska published a Overweight outlook on EPRX, with a target of 19. Market action contradicted the Buy thesis, as shares slipped to 7.82.

Dec 17, 2025

On Dec 17, 2025, Kristen Kluska reaffirmed DBVT with a Overweight rating, targeting 48. Market indecision has kept the 48 target in a holding pattern.

Dec 08, 2025

FULC was rated Overweight by Kristen Kluska on Dec 08, 2025, with a price objective of 24. This case shows how bullish projections can fail, with the stock now below 7.94.

Dec 01, 2025

On Dec 01, 2025, Kristen Kluska initiated coverage on LXEO with a Overweight rating and target of 19. The Buy call has yet to be validated as shares remain 11.56 away from the target.

Nov 06, 2025

Kristen Kluska issued a Overweight recommendation for ZVRA on Nov 06, 2025, price target set at 24. The target of 24 remains in play, though confirmation will depend on future moves.

Sep 30, 2025

Kristen Kluska rated SUPN as Overweight on Sep 30, 2025, setting a price target of 63. The call has proven timely, with shares rising 13.35% toward the price target of 63.

Sep 05, 2025

On Sep 05, 2025, RARE was given a Overweight rating by Kristen Kluska, with a target price of 105. Despite the Buy call, shares fell from 22.61 to 22.61, challenging the optimistic stance.

Sep 03, 2025

PTCT received a Overweight rating from Kristen Kluska on Sep 03, 2025, aiming for 118. Momentum has favored the Buy call, with shares climbing from 68.4 to 68.4, rewarding those who trusted the recommendation.

Aug 27, 2025

On Aug 27, 2025, Kristen Kluska published a Overweight outlook on MNPR, with a target of 74. Shares gained 66.82%, underscoring the accuracy of the bullish outlook toward 74.

Mar 27, 2025

Kristen Kluska on Mar 27, 2025 assigned SLNO a Overweight rating, with a price target of 123. The call has struggled to gain traction, with shares losing 40.99%.

Mar 26, 2025

On Mar 26, 2025, Kristen Kluska reaffirmed XFOR with a Overweight rating, targeting 3. Shares slid 48.65% despite the recommendation, highlighting downside risks.

Mar 20, 2025

CAPR was rated Overweight by Kristen Kluska on Mar 20, 2025, with a price objective of 30. A bullish response from the market helped close the gap of -0.63 to the target.

Mar 19, 2025

On Mar 19, 2025, Kristen Kluska initiated coverage on SRPT with a Overweight rating and target of 163. The Buy call has yet to be validated as shares remain 145.36 away from the target.

Mar 18, 2025

Kristen Kluska issued a Overweight recommendation for MREO on Mar 18, 2025, price target set at 7. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Mar 04, 2025

On Mar 04, 2025, ADMA was evaluated by Kristen Kluska, who gave a Overweight rating and target of 25. Investors saw limited payoff as shares fell short of the 25 target.

Jan 29, 2025

Kristen Kluska rated CLDX as Overweight on Jan 29, 2025, setting a price target of 67. The call has proven timely, with shares rising 20.46% toward the price target of 67.

Jan 02, 2025

On Jan 02, 2025, ETNB was given a Overweight rating by Kristen Kluska, with a target price of 29. The stock rallied 85.96% after the rating, narrowing the gap to the target of 29 and validating the bullish stance.

Dec 17, 2024

ESPR received a Overweight rating from Kristen Kluska on Dec 17, 2024, aiming for 8. Momentum has favored the Buy call, with shares climbing from 3.04 to 3.04, rewarding those who trusted the recommendation.

Dec 17, 2024

On Dec 17, 2024, Kristen Kluska published a Overweight outlook on AQST, with a target of 17. Shares gained 11.43%, underscoring the accuracy of the bullish outlook toward 17.

Nov 22, 2024

Kristen Kluska on Nov 22, 2024 assigned CDXS a Overweight rating, with a price target of 11. The call has struggled to gain traction, with shares losing 72.89%.

Sep 20, 2024

On Sep 20, 2024, Kristen Kluska reaffirmed ABEO with a Overweight rating, targeting 18. Shares slid 14.29% despite the recommendation, highlighting downside risks.

Sep 20, 2024

HUMA was rated Overweight by Kristen Kluska on Sep 20, 2024, with a price objective of 13. This case shows how bullish projections can fail, with the stock now below 1.2.

Sep 20, 2024

On Sep 20, 2024, Kristen Kluska initiated coverage on SKYE with a Overweight rating and target of 14. The Buy call has yet to be validated as shares remain 13.28 away from the target.

Jun 20, 2024

Kristen Kluska issued a Overweight recommendation for TSHA on Jun 20, 2024, price target set at 7. Investors following the Buy call captured upside momentum, with shares now at 4.59.

Apr 30, 2024

On Apr 30, 2024, ATNM was evaluated by Kristen Kluska, who gave a Overweight rating and target of 21. Investors saw limited payoff as shares fell short of the 21 target.